Pharma-Bio Serv (PBSV) Dividends payables (2019 - 2026)

Pharma-Bio Serv (PBSV) reported Dividends payables of $1.7 million for Q1 2026, down 0.56% on a QoQ basis from $1.7 million in Q1 2021.

Pharma-Bio Serv (PBSV) Dividends payables (2019 - 2026) Analysis & Trends

Pharma-Bio Serv's Dividends payables history runs 3 years deep, the most recent figure standing at $1.7 million for Q1 2026.

Dividends payables for Q1 2026 came in at $1.7 million, changed N/A year-over-year; the trailing twelve-month figure through Jan 2026 was $1.7 million (changed N/A YoY), and the FY2019 annual result was $1.7 million, changed N/A from the prior year.
Dividends payables came in at $1.7 million for Q1 2026 at Pharma-Bio Serv, down from $1.7 million in the prior quarter.
In the past five years, Dividends payables ranged from a high of $1.7 million in Q1 2026 to a low of $1.7 million in Q1 2026.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Dividends payables (Qtr)
1	Veeva Systems	24.83 Bn	17.52 Bn	662.02 Mn	-
2	BrightSpring Health Services	13.57 Bn	12.69 Bn	482.22 Mn	-
3	Healthequity	7.20 Bn	6.93 Bn	256.31 Mn	-
4	Hinge Health	5.42 Bn	5.11 Bn	154.23 Mn	-
5	10x Genomics	4.46 Bn	3.92 Bn	106.18 Mn	-
6	Doximity	3.81 Bn	3.06 Bn	125.97 Mn	-
7	Waystar Holding	3.52 Bn	3.36 Bn	268.04 Mn	-
8	Privia Health	2.94 Bn	2.57 Bn	595.71 Mn	-
9	Omnicell	1.76 Bn	1.59 Bn	140.36 Mn	-
10	Pharma-Bio Serv	-	-	902,041.00	-

Download Data